A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice
Clinical trial NCT03337490 · COMPLETED
Trial details
- NCT number
- NCT03337490
- Sponsor
- Mayne Pharma International Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-02
- Primary completion
- 2017-12-04
- Enrollment
- 296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.